AKANDA CORP. Receives Nasdaq Delisting Notice for Negative Stockholders' Equity
Summary
Akanda Corp. received a Nasdaq delisting notice for failing to meet the minimum stockholders' equity requirement, reporting -$11.99 million against a $2.5 million minimum.
Key Events
-
Nasdaq Non-Compliance Notification
Akanda Corp. received a notice from Nasdaq on June 16, 2026, for non-compliance with Listing Rule 5550(b)(1), which requires a minimum of $2.5 million in stockholders' equity.
-
Significant Equity Deficit
The company reported stockholders' equity of approximately -$11.99 million in its Annual Report on Form 20-F for 2025, falling significantly short of the Nasdaq requirement.
-
Delisting Risk and Compliance Plan
The company has 45 calendar days, until July 31, 2026, to submit a plan to regain compliance. Failure to do so could lead to delisting from The Nasdaq Capital Market.
-
Follows Recent Financial Disclosures
This notice directly follows the company's 2025 Annual Report (20-F filed June 9, 2026) which disclosed a $46.8 million net loss and substantial doubt about its ability to continue as a going concern.
Analysis
Akanda Corp. has received a formal notification from Nasdaq regarding non-compliance with the minimum stockholders' equity requirement. The company reported negative stockholders' equity of approximately -$11.99 million in its recent 20-F filing, far below the $2.5 million threshold. This notice puts the company at significant risk of delisting if it cannot present a viable plan to regain compliance within 45 days and execute it within the extended timeframe. This follows recent disclosures of substantial losses and going concern doubts.
At the time of this filing, AKAN was trading at $18.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $9.8M. The 52-week trading range was $2.30 to $209.03. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.